癌症驱动基因的识别基于层次的弱共识模型
Gaoshi Li1,2,3, Zhipeng Hu1,2,3, Xinlong Luo1,2,3
1Key Lab of Education Blockchain and Intelligent Technology, Ministry of Education, Guangxi Normal University, Guilin, 541004 China.
Health information science and systems
|March 11, 2024
概括
这项研究引入了分层弱共识 (HWC) 模型,用于从omics数据中识别癌症驱动基因. 通过整合网络功能和多omics数据来提高准确性,HWC改进了现有的方法.
科学领域:
- 基因组学就是基因组学.
- 生物信息学是一种生物信息学.
- 计算生物学 计算生物学
背景情况:
- 癌症是由体细胞进化过程中累积的基因突变引起的.
- 高通量omics技术产生了庞大的数据集,这给识别癌症驱动基因带来了挑战.
- 基于频率和基于网络的方法等现有方法在识别低突变率驱动因素和整合特征关系方面存在局限性.
研究的目的:
- 通过有效地整合多omics数据和特征相互连接,提出一种用于识别癌症驱动基因的新方法.
- 引入一个新的拓特征,共同突变聚类系数 (CMCC),来自PPI和共同突变超图网络.
- 开发用于驱动基因识别的等级弱共识 (HWC) 模型.
主要方法:
- 分析现有的多主题数据整合方法.
- 通过分析PPI和共突变超图网络,开发共突变聚类系数 (CMCC).
- 整合CMCC,mRNA和miRNA差异表达得分,使用层次弱共识模型创建HWC方法.
主要成果:
- 与七种最先进的方法相比,HWC方法在三种癌症类型中表现出卓越的性能.
- HWC实现了更好的统计评估指数,功能一致性和ROC曲线下的部分面积.
- 提出的方法有效地解决了以前基于频率和基于网络的驱动基因识别技术的局限性.
结论:
- 层次弱共识 (HWC) 模型提供了一种强大而有效的方法来识别癌症驱动基因.
- 将CMCC等新型拓特征与多omics数据相结合,可以提高驱动基因的发现.
- HWC代表了计算机瘤学在了解癌症基因突变方面取得的重大进展.
相关概念视频
01:33Cancer-Critical Genes I: Proto-oncogenes
8.9K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:11Genome-wide Association Studies-GWAS
13.4K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.4K
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
02:21Cancers Originate from Somatic Mutations in a Single Cell
11.9K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
11.9K